484 filings
Page 21 of 25
8-K
MYMD
MyMD Pharmaceuticals Inc
5 Apr 17
Entry into a Material Definitive Agreement
12:00am
NT 10-K
MYMD
MyMD Pharmaceuticals Inc
31 Mar 17
Notice of late annual filing
12:00am
5
MYMD
MyMD Pharmaceuticals Inc
13 Feb 17
Akers Biosciences / BRANDON THOMAS KNOX ownership change
12:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
13 Jan 17
This announcement contains inside information
12:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
10 Jan 17
Akers Biosciences Announces Pricing of Public Offering
12:00am
424B5
MYMD
MyMD Pharmaceuticals Inc
10 Jan 17
Prospectus supplement for primary offering
12:00am
424B5
MYMD
MyMD Pharmaceuticals Inc
6 Jan 17
Prospectus supplement for primary offering
12:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
22 Dec 16
Submission of Matters to a Vote of Security Holders
12:00am
FWP
MYMD
MyMD Pharmaceuticals Inc
16 Nov 16
Free writing prospectus
12:00am
424B5
MYMD
MyMD Pharmaceuticals Inc
16 Nov 16
Prospectus supplement for primary offering
12:00am
EFFECT
MYMD
MyMD Pharmaceuticals Inc
16 Nov 16
Notice of effectiveness
12:00am
424B5
MYMD
MyMD Pharmaceuticals Inc
16 Nov 16
Prospectus supplement for primary offering
12:00am
CORRESP
MYMD
MyMD Pharmaceuticals Inc
15 Nov 16
Correspondence with SEC
12:00am
S-3/A
MYMD
MyMD Pharmaceuticals Inc
15 Nov 16
Shelf registration (amended)
12:00am
10-Q
2016 Q3
MYMD
MyMD Pharmaceuticals Inc
Quarterly report
14 Nov 16
12:00am
DEF 14A
MYMD
MyMD Pharmaceuticals Inc
Definitive proxy
14 Nov 16
12:00am
UPLOAD
MYMD
MyMD Pharmaceuticals Inc
8 Nov 16
Letter from SEC
12:00am
S-3
MYMD
MyMD Pharmaceuticals Inc
24 Oct 16
Shelf registration
12:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
12 Oct 16
Entry into a Material Definitive Agreement
12:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
19 Aug 16
Entry into a Material Definitive Agreement
12:00am